Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal Comparative Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of CG-0255 Besylate and Plavix® in Healthy Participants

NCT07619885 is registered in ClinicalTrials.gov with Shanghai CureGene Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07619885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07619885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal Comparative Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of CG-0255 Besylate and Plavix® in Healthy Participants
Lead sponsor
Shanghai CureGene Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
June 30, 2026
Completion date
December 31, 2026
Enrollment
136 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes (acs), peripheral arterial disease, recent myocardial infarction, recent stroke